Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 100 movers: St James's Place boosted by JPM note; Fresnillo falls
(Sharecast News) - London's FTSE 100 was up 0.5% at 8,673 in afternoon trade on Friday. St James's Place jumped to the top of the index as JPMorgan reiterated its 'strong conviction' on the overweight-rated stock and lifted the price target to 1,310p from 1,205p.
"St. James's Place remains a top conviction within our coverage universe," it said.
The bank said it was updating its St. James's Place model, incorporating the reported Q1 assets under management, while also reflecting in its estimates the good market performance of recent weeks.
"As a result, we increase our 2025-27 underlying cash earnings per share estimates by 8-12%, primarily thanks to a circa 6% increase in our funds under management assumptions," it said.
"The higher FUM leads to a 4%-6% increase in net income, which is then amplified at the EPS level by operating margins as we make no changes to our cost estimates," said JPM, which lifted its price target accordingly.
It said that impressive strength in net flows recorded over past 12 months demonstrate to the bank that St. James's Place is well on track to continue to grow and capture market share in the UK wealth management market.
GSK, Shell and BP were among the gainers. Russ Mould, investment director at AJ Bell, said: "AstraZeneca, Shell and GSK were the biggest contributors to the FTSE 100 in terms of index points, suggesting that investors were fishing for opportunities among areas that have recently been weak.
"Pharma stocks have been volatile of late amid fears of tariffs on the sector, while a pullback in oil prices dragged down the big oil producers yesterday."
Fresnillo lost its shine after announcing the sale of the majority of its stake in MAG Silver following Pan American Silver's agreement to acquire MAG. It said the resulting reduced shareholding in Pan American would no longer align with its strategic investment objectives.
FTSE 100 - Risers
St James's Place (STJ) 1,102.00p 2.89% JD Sports Fashion (JD.) 93.08p 1.99% F&C Investment Trust (FCIT) 1,107.00p 1.65% International Consolidated Airlines Group SA (CDI) (IAG) 326.10p 1.56% GSK (GSK) 1,383.00p 1.50% Shell (SHEL) 2,509.00p 1.46% BP (BP.) 373.35p 1.38% British American Tobacco (BATS) 3,117.00p 1.30% Pershing Square Holdings Ltd NPV (PSH) 3,778.00p 1.18% Admiral Group (ADM) 3,304.00p 1.16%
FTSE 100 - Fallers
Anglo American (AAL) 2,090.50p -2.45% Melrose Industries (MRO) 464.60p -2.31% Fresnillo (FRES) 994.00p -2.17% Hikma Pharmaceuticals (HIK) 2,054.00p -1.44% Smurfit Westrock (DI) (SWR) 3,473.00p -1.36% 3i Group (III) 3,966.00p -1.34% Marks & Spencer Group (MKS) 352.30p -1.32% Standard Chartered (STAN) 1,134.00p -1.31% Antofagasta (ANTO) 1,834.50p -1.16% Kingfisher (KGF) 312.70p -1.08%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.